1. Aleksandrova, E.A., Ivanova, V.I., and Kuznetsova, M.Yu., Clusters and cluster initiatives in the Russian biopharmaceutical industry: Identification, structure, geography, Vestn. S.-Peterb. Univ.: Menedzh., 2019, vol. 18, no. 3, pp. 341–374.
2. Bignami, F., Mattsson, P., and Hoekman, J., The importance of geographical distance to different types of R&D collaboration in the pharmaceutical industry, Ind. Innovation, 2020, vol. 27, no. 5, pp. 513–537.
3. Boasson, V., Boasson, E., Macpherson, A., and Shin, H.H., Firm value and geographic competitive advantage: Evidence from the U.S. pharmaceutical industry, J. Bus., 2005, vol. 78, no. 6, pp. 2465–2495.
4. Bogachev, I.I. and Rodionova, I.A., Characteristics of the state and problems of development of the pharmaceutical cluster in the Kaluga oblast, Vestn. Ross. Univ. Druzh. Nar., Ser.: Ekon., 2014, no. 1, pp. 24–34.
5. Daemmrich, A., Where is the Pharmacy to the World? International Regulatory Variation and Pharmaceutical Industry Location, working paper, Harvard Business School, 2009. https://www.hbs.edu/faculty/Publication%20Files/09-118.pdf.